Skip to content
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch

Johnson & Johnson

Latest 6 February 2025

Thousands to sue Johnson & Johnson in UK over alleged talc link to cancer

Lawyers representing 3,500 claimants are preparing to sue the pharmaceutical firm Johnson & Johnson (J&J) over alleged links between talcum powder and cancer, in what is expected to be one…

Corporate Dispatch · 12 Aug 2022 J&J to end global sales of talc-based baby powder Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker announced, more than two years after it ended… Coronavirus · 15 Dec 2021 EU regulator backs J&J COVID-19 booster dose in adults Dec 15 (Reuters) - The European Union's drug regulator on Wednesday recommended that a booster dose of Johnson & Johnson's COVID-19 vaccine… Business · 12 Nov 2021 Healthcare giant Johnson & Johnson to split into two companies Nov 12 (Reuters) - Healthcare conglomerate Johnson & Johnson said on Friday it is planning to break up into two companies, splitting… Comuniq.EU · 1 Oct 2021 EU finds J&J COVID shot possibly linked to another rare clotting condition Oct 1 (Reuters) - The European Union's drug regulator said on Friday there is a possible link between rare cases of bloods… Coronavirus · 3 Sep 2021 UPDATED: EU reviewing cases of rare body inflammation after COVID-19 shots Europe's medicines regulator said on Friday it was reviewing if there was a risk of a rare inflammatory condition after inoculation with… Coronavirus · 6 Aug 2021 South African study shows J&J vaccine protects against death Johnson & Johnson COVID-19 vaccine is working well in South Africa, offering protection against severe disease and death, the head of a… Comuniq.EU · 22 Jul 2021 EU lists rare nerve disorder as side-effect of J&J COVID-19 vaccine Europe's medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from… USA · 21 Jul 2021 J&J raises revenue forecast, estimates $2.5 bln in COVID-19 vaccine sales Johnson & Johnson raised its 2021 revenue estimates on Wednesday and forecast it would sell $2.5 billion worth of its COVID-19 vaccine… USA · 2 Jul 2021 UPDATED: J&J’s COVID-19 vaccine shows promise against Delta variant Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine showed promise against the highly contagious Delta variant in a laboratory…